Piramal Group Executive and Leadership Team

Sai Ponugoti, the Chief Executive Officer at Piramal Group, directs the overarching strategic vision for the global conglomerate. Overseeing the integration of pharmaceuticals, financial services, and real estate, the Chief Executive Officer ensures operational synergy across all business units. This leadership role involves driving long-term value creation by leveraging the company's artificial intelligence platform to optimize market performance. By aligning corporate objectives with emerging industry trends, Sai Ponugoti fosters a culture of innovation and sustainable growth. The Chief Executive Officer maintains close collaboration with the Board to refine capital allocation strategies and expand the company's footprint in international markets. Through rigorous oversight of diverse verticals, Ponugoti secures the competitive positioning of the organization. This executive leadership remains focused on scaling the business model to meet evolving consumer demands while maintaining the highest standards of corporate governance and operational excellence across all global operations.

Yesh Nadkarni, the Chief Executive Officer - Wholesale Lending at Piramal Group, manages the strategic direction of the wholesale lending division. Overseeing complex credit portfolios and institutional partnerships, the Chief Executive Officer - Wholesale Lending drives the expansion of financial solutions tailored for diverse industry verticals. This leadership role involves architecting robust risk management frameworks to ensure portfolio stability while pursuing aggressive growth targets. By integrating advanced data analytics into the lending process, Yesh Nadkarni enhances the efficiency of capital deployment across the organization. The Chief Executive Officer - Wholesale Lending collaborates with internal stakeholders to refine product offerings and strengthen market presence within the financial services sector. Through disciplined execution of lending strategies, Nadkarni supports the broader mission of the company to provide innovative financial solutions. This executive focus remains on maintaining high asset quality and delivering consistent returns for the firm's stakeholders in a competitive global landscape.

Vivek Valsaraj, the Chief Financial Officer, Piramal Pharma Limited at Piramal Group, directs the financial strategy and fiscal health of the pharmaceutical division. Overseeing capital budgeting, financial reporting, and treasury operations, the Chief Financial Officer, Piramal Pharma Limited ensures alignment with the company's broader financial objectives. This leadership role involves managing complex financial risks and optimizing the cost structure to support long-term profitability. By implementing rigorous financial controls and performance metrics, Vivek Valsaraj drives transparency and accountability across the pharmaceutical business. The Chief Financial Officer, Piramal Pharma Limited collaborates with executive leadership to evaluate investment opportunities and ensure the efficient allocation of resources. Through the strategic management of financial assets, Valsaraj supports the organization's mission to deliver high-quality healthcare solutions. This executive focus remains on maintaining a strong balance sheet and ensuring the financial sustainability of the firm's pharmaceutical operations in a dynamic global market.

Jeff Hampton, the President and Chief Operating Officer, Piramal Critical Care at Piramal Group, manages the operational execution and strategic growth of the critical care business unit. Overseeing global supply chain logistics, manufacturing excellence, and product distribution, the President and Chief Operating Officer, Piramal Critical Care ensures the seamless delivery of essential medical products. This leadership role involves driving operational efficiency and quality compliance to meet the rigorous demands of the healthcare industry. By optimizing production processes and expanding market reach, Jeff Hampton strengthens the company's position in the critical care sector. The President and Chief Operating Officer, Piramal Critical Care collaborates with regional teams to navigate complex regulatory environments and ensure consistent product availability. Through the implementation of lean manufacturing principles, Hampton enhances the overall performance of the division. This executive leadership remains dedicated to operational excellence and the continuous improvement of critical care services on a global scale.

Jatin Lal, the President, Mergers & Acquisitions at Piramal Group, directs the identification, evaluation, and execution of strategic investment opportunities. Overseeing the inorganic growth strategy, the President, Mergers & Acquisitions ensures that all acquisitions align with the company's long-term vision and portfolio diversification goals. This leadership role involves conducting thorough due diligence and negotiating complex transactions to expand the firm's presence in key industry verticals. By analyzing market trends and competitive landscapes, Jatin Lal identifies high-value targets that enhance the organization's technological and operational capabilities. The President, Mergers & Acquisitions collaborates with the C-suite to integrate new assets and realize synergies across the conglomerate. Through the disciplined management of the acquisition pipeline, Lal drives the expansion of the company's global footprint. This executive focus remains on creating shareholder value through strategic partnerships and the successful integration of new businesses into the existing corporate structure.

Arvind Iyer, the Chief Marketing Officer at Piramal Group, directs the global brand strategy and market positioning for the conglomerate. Overseeing the development of integrated marketing campaigns, the Chief Marketing Officer ensures consistent messaging across the pharmaceutical, financial, and real estate sectors. This leadership role involves utilizing artificial intelligence to analyze consumer behavior and optimize engagement strategies across digital platforms. By aligning marketing initiatives with the company's core business objectives, Arvind Iyer drives brand equity and customer acquisition. The Chief Marketing Officer collaborates with divisional leaders to tailor communication strategies for specific market segments, ensuring the organization remains at the forefront of industry innovation. Through the implementation of data-driven marketing tactics, Iyer enhances the visibility of the company's diverse service offerings. This executive leadership remains dedicated to building a cohesive brand identity that reflects the firm's commitment to excellence and technological advancement in the global marketplace.

Viral Gandhi, the Chief Technology Officer, Piramal Pharma Piramal Group & Piramal Foundation at Piramal Group, architects the digital infrastructure and technological roadmap for the organization. Overseeing the deployment of artificial intelligence platforms, the Chief Technology Officer, Piramal Pharma Piramal Group & Piramal Foundation ensures that technological capabilities support the company's diverse business interests. This leadership role involves driving digital transformation initiatives that enhance operational efficiency and data security across all departments. By fostering innovation in software development and systems integration, Viral Gandhi enables the firm to leverage data for strategic decision-making. The Chief Technology Officer, Piramal Pharma Piramal Group & Piramal Foundation collaborates with cross-functional teams to implement scalable solutions that address complex industry challenges. Through the continuous modernization of IT systems, Gandhi secures the technological foundation necessary for sustained growth. This executive focus remains on maintaining a competitive edge through cutting-edge digital tools and robust cybersecurity protocols.